Corticosteroid for IgA Nephropathy: Are They Really Therapeutic? | Zendy

Yujia Lin | Zendy; Junya Jia | Zendy; Yipeng Guo | Zendy; Dandan He | Zendy; Yaru Zhang | Zendy; Fuzhen Wang | Zendy; Tiekun Yan | Zendy; Youxia Liu | Zendy; Shan Lin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Corticosteroid for IgA Nephropathy: Are They Really Therapeutic?

Author(s) -

Yujia Lin,

Junya Jia,

Yipeng Guo,

Dandan He,

Yaru Zhang,

Fuzhen Wang,

Tiekun Yan,

Youxia Liu,

Shan Lin

Publication year - 2018

Publication title -

american journal of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.394

H-Index - 85

eISSN - 1421-9670

pISSN - 0250-8095

DOI - 10.1159/000489580

Subject(s) - medicine , proteinuria , prednisone , nephropathy , renal function , kidney disease , randomized controlled trial , placebo , corticosteroid , gastroenterology , cochrane library , creatinine , urology , kidney , endocrinology , diabetes mellitus , pathology , alternative medicine

IgA nephropathy (IgAN) is a common chronic glomerular disease that, in most patients, slowly progresses to end-stage kidney disease. The therapy with corticosteroid in IgAN is still a worldwide problem that is confusing the clinicians.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research